Physician profile
Jacob Jasinski
NPI 1861912321
$5,189.56
in general payments reported to CMS, 2019-2025
10 companies · $2,413 in 2025
The $2,413 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2021: $369 · 2023: $406 · 2024: $1,853 · 2025: $2,413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,120 · Food and Beverage: $1,552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,119.82 |
| Food and Beverage | $1,552.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,688.91 | 2021-2024 | Viper |
| Pinnacle, INC | $1,167.38 | 2025 | |
| Arthrex, INC. | $1,087.33 | 2025 | |
| Alphatec Spine, INC | $335.83 | 2023 | Battalion Tlif - PC, Invictus Mis, Solus Alif |
| Medtronic, INC. | $270.43 | 2021-2025 | Strata, Pipeline |
| Medtronic USA, INC. | $148.50 | 2019 | |
| Si-Bone, INC. | $146.14 | 2024 | |
| Novocure INC. | $139.86 | 2021 | |
| Integra Lifesciences Corporation | $135.00 | 2024 | Cusa Clarity, Codman Hakim, Codman Certas |
| Stryker Corporation | $70.18 | 2023 | Prolift |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Jasinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.